Immunovant, Inc. IMVT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

47/100

2/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Immunovant, Inc. (IMVT), dont 16 achats et 31 ventes. Le total des achats d'initiés s'élève à $369.18M et le total des ventes d'initiés à $10.29M.

Les initiés notables ayant une activité récente comprennent Venker Eric, Van Tuyl Christopher, Gloria Melanie. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — IMVT

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-02	Venker Eric	Chief Executive Officer	Vente Informative	1,409	$24.60	$34.66K	19,561
2026-04-01	Venker Eric	Chief Executive Officer	Restitution d'Actions	334,960	$25.10	$8.41M	33,790
2026-03-18	Van Tuyl Christopher	Chief Legal Officer	Vente Informative	2,877	$24.97	$71.84K	147,053
2026-02-25	Gloria Melanie	Chief Operating Officer	Vente Informative	942	$28.90	$27.22K	170,273
2026-01-21	Stout Jay S	Chief Technology Officer	Vente Informative	1,977	$26.03	$51.46K	197,634
2026-01-07	Stout Jay S	Chief Technology Officer	Vente Informative	55	$26.92	$1.48K	199,611
2025-12-18	Van Tuyl Christopher	Chief Legal Officer	Vente Informative	2,284	$27.38	$62.54K	149,930
2025-12-12	Roivant Sciences Ltd.	10 Percent Owner	Achat Informatif	16,666,666	$21.00	$350M	113,317,007
2025-12-01	Fromkin Andrew J.	Director	Vente Informative	2,898	$23.95	$69.41K	85,852
2025-12-01	Hughes Douglas J.	Director	Vente Informative	1,909	$23.96	$45.74K	120,773
2025-11-20	Gloria Melanie	Chief Operating Officer	Vente Informative	2,375	$23.97	$56.93K	173,511
2025-10-22	Stout Jay S	Chief Technology Officer	Vente Informative	2,520	$19.03	$47.96K	200,814
2025-10-22	Geffner Michael	Chief Medical Officer	Vente Informative	2,595	$19.03	$49.38K	217,958
2025-10-08	Stout Jay S	Chief Technology Officer	Vente Informative	1,585	$16.30	$25.84K	203,334
2025-10-08	Geffner Michael	Chief Medical Officer	Vente Informative	1,272	$16.30	$20.73K	220,553
2025-07-28	Venker Eric	Chief Executive Officer	Attribution de RSU	189,900	$16.76	$3.18M	189,900
2025-07-23	Stout Jay S	Chief Technology Officer	Vente Informative	2,805	$18.15	$50.91K	204,919
2025-07-23	Geffner Michael	Chief Medical Officer	Vente Informative	2,385	$18.15	$43.29K	221,825
2025-07-09	Stout Jay S	Chief Technology Officer	Vente Informative	1,519	$17.24	$26.19K	207,724
2025-07-09	Geffner Michael	Chief Medical Officer	Vente Informative	1,160	$17.24	$20K	224,210
2025-05-01	Girao Tiago	Chief Financial Officer	Attribution de RSU	208,388	-	-	208,388
2025-05-01	Bauer Jake	Director	Attribution de RSU	25,016	-	-	25,016
2025-05-01	Susman Robert Graham	Director	Attribution de RSU	25,016	-	-	25,016
2025-04-23	Stout Jay S	Chief Technology Officer	Vente Informative	1,925	$14.79	$28.47K	209,243
2025-04-23	Geffner Michael	Chief Medical Officer	Vente Informative	2,349	$14.79	$34.74K	225,370
2025-04-21	Girao Tiago	Officer	Inconnu	-	-	-	-
2025-04-18	Bauer Jake	Officer	Inconnu	-	-	-	-
2025-04-18	Susman Robert Graham	Officer	Inconnu	-	-	-	-
2025-04-16	Salzmann Peter	Chief Executive Officer	Vente Informative	8,321	$14.89	$123.9K	1,178,191
2025-04-16	Barnett Eva Renee	Chief Financial Officer	Vente Informative	2,993	$14.89	$44.57K	396,774
2025-04-09	Salzmann Peter	Chief Executive Officer	Vente Informative	28,094	$12.99	$364.94K	1,186,512
2025-04-01	Migausky George V	Director	Attribution de RSU	7,600	$15.20	$115.52K	7,600
2025-04-01	Fromkin Andrew J.	Director	Attribution de RSU	7,600	$15.20	$115.52K	7,600
2025-04-01	Pande Atul	Director	Attribution de RSU	7,600	$15.20	$115.52K	7,600
2025-04-01	Torti Frank	Director	Attribution de RSU	93,599	$15.20	$1.42M	93,599
2025-04-01	Stout Jay S	Chief Technology Officer	Attribution de RSU	107,297	$15.20	$1.63M	107,297
2025-04-01	Hughes Douglas J.	Director	Attribution de RSU	7,600	$15.20	$115.52K	7,600
2025-04-01	Van Tuyl Christopher	Chief Legal Officer	Attribution de RSU	71,531	$15.20	$1.09M	71,531
2025-04-01	Salzmann Peter	Chief Executive Officer	Attribution de RSU	374,395	$15.20	$5.69M	374,395
2025-04-01	Barnett Eva Renee	Chief Financial Officer	Attribution de RSU	125,180	$15.20	$1.9M	125,180
2025-04-01	Gloria Melanie	Chief Operating Officer	Attribution de RSU	107,297	$15.20	$1.63M	107,297
2025-04-01	Geffner Michael	Chief Medical Officer	Attribution de RSU	143,063	$15.20	$2.17M	143,063
2025-03-07	Fromkin Andrew J.	Director	Vente Informative	1,384	$19.96	$27.62K	91,913
2025-02-19	Salzmann Peter	Chief Executive Officer	Vente Informative	15,439	$20.86	$322.06K	948,786
2025-02-19	Macias William L.	Chief Medical Officer	Vente Informative	2,055	$20.86	$42.87K	357,353
2025-02-19	Barnett Eva Renee	Chief Financial Officer	Vente Informative	2,814	$20.86	$58.7K	321,952
2025-01-22	Stout Jay S	Chief Technology Officer	Vente Informative	2,195	$23.59	$51.78K	139,991
2025-01-22	Geffner Michael	Chief Medical Officer	Vente Informative	2,657	$23.59	$62.68K	132,314
2025-01-15	Salzmann Peter	Chief Executive Officer	Vente Informative	415	$24.19	$10.04K	964,225
2025-01-15	Macias William L.	Chief Medical Officer	Vente Informative	19	$24.19	$459.61	359,408

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration